Skip to content

Predictors of Outcome and Natural History in Patients With Cervical Spondylotic Myelopathy

Predictors of Outcome and Natural History in Patients With Cervical Spondylotic Myelopathy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02936245
Enrollment
350
Registered
2016-10-18
Start date
2013-10-31
Completion date
2020-07-31
Last updated
2016-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Spondylosis With Myelopathy

Brief summary

Cervical spondylotic myelopathy (CSM) is the most frequent cause of myelopathy in those over the age of 50. They claim that surgical treatment of myelopathy, especially of the mild and moderate forms, has not shown better results than conservative treatment in the long term, and criteria for the indication and the timing of the operation have not been established. In order to get some more reliable data, a long-term follow up observational study will be started to confirm the effects of long term for conservative treatment.

Detailed description

Cervical spondylotic myelopathy (CSM) is the most frequent cause of myelopathy in those over the age of 50 \[1\]. It is believed to have a generally progressive course over a period of years, with sudden acceleration especially following a slight head and neck injury, leading to significant disability \[2, 3\]. The treatment of CSM remains a problem, particularly in the mild and moderate forms without rapid progression. Excellent outcomes for surgery have been presented in many studies. All of the studies, however, are retrospective, and many lack a clear design, standard criteria, control groups, and sufficient follow-up, so it is difficult to compare \[4, 5, 6\]. Furthermore, several studies and critical reviews are not so optimistic. They claim that surgical treatment of myelopathy, especially of the mild and moderate forms, has not shown better results than conservative treatment in the long term, and criteria for the indication and the timing of the operation have not been established \[7, 8, 9\]. Twenty-five percent of patients with laminoplasty suffer from severe neck and shoulder pain for more than 3 months \[10\], with significant morbidity from the iliac crest donor site etc. Surgery to decompress and stabilize the spine is often advocated for severe or progressive symptoms, with mixed results. About two-thirds of patients improve with surgery, whereas surgery is not successful in 15% to 30% of cases \[11\]. In order to get some more reliable data, a long-term follow up observational study will be started to confirm the effects of long term for conservative treatment.

Interventions

We will not assign specific intervention in this research. We will record their baseline characteristics, received treatment, and assess the outcomes to analysis the predictors of outcome and natural history in patients with cervical spondylotic myelopathy.

Sponsors

Shanghai University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Clinical signs and symptoms of cervical cord dysfunction 2. Magnetic resonance imaging (MRI) criteria for cervical multisegmental cord compression and/or myelopathy due to spondylosis (including soft disc herniations) with or without developmentally narrow spinal canal 3. Age under 75 years 4. Patient's consent to conservative treatment It has been suggested that magnetic resonance imaging

Exclusion criteria

1. Spinal cord compression, without clinical symptoms 2. Previous surgery on the cervical spine 3. Uncertainty about the presence of significant additional diseases (such as Motor neurone disease, progressive polyarthritis) 4. Cervical cord dysfunction due to tumors, trauma, soft disc herniation or previous surgery 5. Serious that require a surgical procedure

Design outcomes

Primary

MeasureTime frameDescription
Japanese Orthopaedic Association scale3 yearsJapanese Orthopaedic Association scale assessed for 3 years

Secondary

MeasureTime frameDescription
Adverse Event6 months, 1, 2, 3,4 and 5 yearsAdverse Event recorded 6 months, 1, 2, 3,4 and 5 years
Visual Analogue Scale6 months, 1, 2, 3,4 and 5 yearsVisual Analogue Scale assessed for 6 months, 1, 2, 3,4 and 5 years
the Medical Outcomes Study short form health survey-366 months, 1, 2, 3,4 and 5 yearsassessed for 6 months, 1, 2, 3,4 and 5 years
Neck Disability Index6 months, 1, 2, 3,4 and 5 yearsNeck Disability Index assessed for 6 months, 1, 2, 3,4 and 5 years
Japanese Orthopaedic Association scale6 months, 1, 2, 4 and 5 yearsJapanese Orthopaedic Association scale assessed for 6 months, 1, 2, 3,4 and 5 years

Countries

China

Contacts

Primary ContactCui / Xue-jun, PhD
13917715524@139.com18917763017
Backup ContactYao / Min, PhD
yaomin19871223@126.com13764102508

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026